GlassScriptPhysician profile
Katherine M Chen
NPI 1902043912
$7,304.53
in general payments reported to CMS, 2019-2025
42 companies · $2,292 in 2025
The $2,292 reported for 2025 was more than what 91% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $708 · 2020: $136 · 2021: $459 · 2022: $560 · 2023: $1,417 · 2024: $1,733 · 2025: $2,292.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,048 · Long Term Medical Supply Or Device Loan: $393.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,048.40 |
| Long Term Medical Supply Or Device Loan | $392.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,058.60 | 2019-2025 | Infinity Adaptis, Citrefix, Infinity |
| Smith+Nephew, INC. | $782.07 | 2019-2025 | Grafix Pl, Stravix Pl, Oasis |
| Integra Lifesciences Corporation | $719.37 | 2019-2025 | Integra, Acell, Integra Dermal Regeneration Template |
| Treace Medical Concepts, INC. | $410.22 | 2023-2025 | |
| Zimmer Biomet Holdings, INC. | $272.58 | 2019-2023 | Stratum Foot Plating System, Nextremity General Instrument, Ti Cannulated Screws |
| Kerecis Limited | $208.11 | 2022-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Abbvie INC. | $190.97 | 2021-2025 | Dalvance |
| Tactile Systems Technology INC | $170.10 | 2023-2024 | Entre Plus, Flexitouch Plus |
| Biocomposites INC | $143.18 | 2025 | Stimulan |
| Guard Medical INC. | $113.76 | 2024 | Npseal Large |
| Comsort, INC | $100.00 | 2019 | |
| Ucb, INC. | $86.64 | 2024-2025 | Bimzelx |
| Convatec INC. | $72.51 | 2023-2024 | |
| Axogen | $69.25 | 2019-2025 | |
| Cumberland Pharmaceuticals, INC. | $65.66 | 2023-2024 | Vibativ |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $65.20 | 2023-2025 | Cmf |
| Amgen INC. | $64.37 | 2024-2025 | Krystexxa |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $60.18 | 2022-2025 | Jublia |
| Paratek Pharmaceuticals, INC. | $58.38 | 2022-2025 | Nuzyra |
| Allergan, INC. | $56.50 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $49.16 | 2019 | |
| Seapearl East, INC | $44.29 | 2023-2024 | |
| Cashflow Solutions, LLC | $40.48 | 2024-2025 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Paragon 28, INC. | $38.52 | 2022-2025 | Silverback |
| Trilliant Surgical LLC. | $36.81 | 2023 | Arsenal Ankle 10 Hole 1/3 Tubular Plate |
| Sandoz INC. | $35.04 | 2019 | |
| Medshape, INC. | $30.20 | 2023 | Dynanail Helix, Washer, 15 Mm |
| Kowa Pharmaceuticals America, INC. | $25.70 | 2022-2023 | Seglentis |
| Medtronic, INC. | $25.55 | 2021 | |
| Organogenesis INC. | $22.13 | 2023 | Puraply |
| Biowound Solutions, INC. | $20.81 | 2025 | Bio-Connekt |
| Musculoskeletal Transplant Foundation INC. | $17.51 | 2023 | |
| Wright Medical Technology, INC. | $17.13 | 2019 | |
| Aroa Biosurgery Incorporated | $16.40 | 2019-2020 | |
| Ani Pharmaceuticals, INC. | $15.83 | 2025 | Oxistat |
| Avanos Medical | $15.33 | 2019 | |
| Dynasplint Systems INC. | $15.20 | 2025 | Dynasplint |
| Depuy Synthes Sales INC. | $15.10 | 2020 | |
| Averitas Pharma INC. | $15.08 | 2025 | Qutenza |
| Sebela Pharmaceuticals INC. | $13.88 | 2020 | |
| Nabriva Therapeutics, Plc | $13.79 | 2020 | |
| Heron Therapeutics, INC. | $12.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.